SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 92 filers reported holding SANA BIOTECHNOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,416,471 | -56.4% | 442,577 | -20.2% | 0.00% | -50.0% |
| Q1 2024 | $5,545,880 | +86.7% | 554,588 | -23.8% | 0.00% | +100.0% |
| Q4 2023 | $2,970,379 | -0.5% | 728,034 | -5.6% | 0.00% | 0.0% |
| Q3 2023 | $2,985,469 | -35.2% | 771,439 | -0.2% | 0.00% | -50.0% |
| Q2 2023 | $4,605,799 | +180448.8% | 772,785 | -0.9% | 0.00% | +100.0% |
| Q1 2023 | $2,551 | -10.9% | 780,075 | +7.7% | 0.00% | 0.0% |
| Q4 2022 | $2,863 | -99.9% | 724,625 | +65.6% | 0.00% | 0.0% |
| Q3 2022 | $2,626,000 | -32.5% | 437,607 | -27.7% | 0.00% | -50.0% |
| Q2 2022 | $3,893,000 | +52.5% | 605,507 | +62.8% | 0.00% | +100.0% |
| Q1 2022 | $2,552,000 | -37.1% | 371,967 | +46.3% | 0.00% | 0.0% |
| Q4 2021 | $4,059,000 | -62.4% | 254,179 | -41.1% | 0.00% | -66.7% |
| Q3 2021 | $10,781,000 | +81.0% | 431,584 | +42.4% | 0.00% | +50.0% |
| Q2 2021 | $5,956,000 | -73.1% | 302,978 | -54.3% | 0.00% | -71.4% |
| Q1 2021 | $22,175,000 | – | 662,555 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Trustees of Columbia University in the City of New York | 281,250 | $6,334,000 | 9.69% |
| Flagship Pioneering Inc. | 34,239,018 | $771,063,000 | 8.08% |
| Crestline Management, LP | 3,210,937 | $72,310,000 | 6.80% |
| SB Management Ltd | 2,209,004 | $49,747,000 | 5.10% |
| Omega Fund Management, LLC | 843,750 | $19,001,000 | 2.13% |
| HARVARD MANAGEMENT CO INC | 1,163,601 | $26,204,000 | 1.54% |
| Alphabet Inc. | 2,812,500 | $63,338,000 | 1.50% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 387,508 | $8,727,000 | 1.03% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 4,131,249 | $93,036,000 | 0.53% |
| Dragoneer Investment Group | 1,500,000 | $33,780,000 | 0.44% |